There is evidence that ESR1 gene fusions in estrogen receptor-positive breast cancer promote endocrine therapy resistance and metastasis, thus ESR1 gene fusions may have a role in ovarian cancer progression34. The gene discussed is ESR1; the disease is breast carcinoma.